Empagliflozin for rheumatoid arthritis patients on methotrexate
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests whether adding empagliflozin to methotrexate helps control active rheumatoid arthritis and protects joints. It may offer a new treatment option for people whose disease is still active despite methotrexate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active rheumatoid arthritis (not in remission) as measured by a standard joint score.
- You are between 18 and 60 years old.
- You are not pregnant or breastfeeding.
- You have no serious kidney or liver disease.
- You have no blood disorders like severe anemia or low white blood cells.
- You are not on other advanced biologic medications for RA in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding silymarin (a herbal supplement) to standard methotrexate treatment can help people with active rheumatoid arthritis. It aims to see if it reduces joint inflammation and improves symptoms.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
This study tests a methotrexate injection (given under the skin) for people with moderate to severe rheumatoid arthritis who haven't taken methotrexate before. Researchers want to see how the medicine builds up in your body and if it helps control your symptoms.
This study looks at how well methotrexate injections work in people with rheumatoid arthritis. It is designed for patients who are starting or changing to this type of methotrexate treatment.
This trial tests if empagliflozin, a medicine used for diabetes, can help protect kidney function in people with active lupus nephritis. You may be eligible if you have a lupus kidney flare with significant protein in your urine.
This trial tests whether increasing your methotrexate dose or switching from pills to injections can better control active rheumatoid arthritis. It's for people already taking a stable, moderate dose of methotrexate but still having joint swelling and symptoms.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.